Back to News
Market Impact: 0.12
Paretor Licenses ETAERION™ Technology to Lumoria Skin Science
Source: PR Newswire
Healthcare & BiotechTechnology & InnovationProduct Launches
Lumoria Skin Science LLC and Paretor LLC announced a new venture to develop a skin-specific application of Paretor's ETAERION™ mineral nanocolloid materials technology. The announcement signals an early-stage product-development initiative in life-science skincare, but no financial terms, development timeline, commercialization plans, or clinical data were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Ryanair CEO warns fares could rise by up to 20% in 2027 as fuel bill jumps by $2.2 billion
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- BTIG cuts Acumen Pharmaceuticals stock price target to $1 on trial results
- Aehr Test Systems earnings on deck amid AI chip boom
- Adeia earnings on deck: Can diversification offset Pay-TV woes?
- Wells Fargo raises Abbvie stock price target to $340 on pipeline